Id	260
VARIANT_NAME	BCR::ABL
GENE_NAME	ABL1
EVIDENCE_RATING	5
EVIDENCE_LEVEL	A
CERTANITY	HIGH
DISEASE_NAME	Chronic Myeloid Leukemia
DRUG_NAMES	Imatinib, 
SOURCE_SOURCE_TYPE	PUBMED
DATE_SYNCHRONIZED	2022-11-03 22-04-36